1. Home
  2. MDBH vs CELU Comparison

MDBH vs CELU Comparison

Compare MDBH & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDBH
  • CELU
  • Stock Information
  • Founded
  • MDBH 1997
  • CELU 2016
  • Country
  • MDBH United States
  • CELU United States
  • Employees
  • MDBH N/A
  • CELU N/A
  • Industry
  • MDBH
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDBH
  • CELU Health Care
  • Exchange
  • MDBH Nasdaq
  • CELU Nasdaq
  • Market Cap
  • MDBH 42.1M
  • CELU 42.2M
  • IPO Year
  • MDBH 2023
  • CELU N/A
  • Fundamental
  • Price
  • MDBH $5.37
  • CELU $2.00
  • Analyst Decision
  • MDBH
  • CELU
  • Analyst Count
  • MDBH 0
  • CELU 0
  • Target Price
  • MDBH N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • MDBH 4.7K
  • CELU 75.7K
  • Earning Date
  • MDBH 08-12-2025
  • CELU 05-08-2025
  • Dividend Yield
  • MDBH N/A
  • CELU N/A
  • EPS Growth
  • MDBH N/A
  • CELU N/A
  • EPS
  • MDBH 0.84
  • CELU N/A
  • Revenue
  • MDBH $3,574,131.00
  • CELU $54,220,000.00
  • Revenue This Year
  • MDBH N/A
  • CELU $23.29
  • Revenue Next Year
  • MDBH N/A
  • CELU N/A
  • P/E Ratio
  • MDBH $6.07
  • CELU N/A
  • Revenue Growth
  • MDBH N/A
  • CELU 138.11
  • 52 Week Low
  • MDBH $3.61
  • CELU $1.00
  • 52 Week High
  • MDBH $12.00
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • MDBH 62.86
  • CELU 51.94
  • Support Level
  • MDBH $4.30
  • CELU $1.80
  • Resistance Level
  • MDBH $4.73
  • CELU $2.26
  • Average True Range (ATR)
  • MDBH 0.30
  • CELU 0.18
  • MACD
  • MDBH 0.08
  • CELU 0.02
  • Stochastic Oscillator
  • MDBH 74.33
  • CELU 48.25

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: